fda compounding glp-1 crackdown news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Beth Siemer and Brian Malkin

Case Info Ozempic Mounjaro GLP-1 Gastroparesis Lawsuit Popular GLP-1 medications used for diabetes and weight loss may cause severe side effects which may result in hospitalization, permanent injury, or other serious complications

The increasingly nuanced molecular subtypes of breast cancer have enhanced the comprehension and precision treatment of this disease

699,700 In advanced stages, structural changes such as regenerative nodules, lobular disruption, and portal hypertension, along with related complications, are common

The difference is that you are more likely to have unused solution in the 60 mg vial if you are on a low dose

Some evidence suggests that increasing NAD may lower the risk for obesity and metabolic syndrome and the conditions they can cause, including heart disease, type 2 diabetes, and stroke, but the science is mixed with some research showing no improvements related to insulin resistance